Trial intelligence / Profile preview

Novaferon in chronic hepatitis B

ChiCTR-TRC-10000982Phase 4Completed

Sponsor
Beijing YouAn Hospital
Start
Jul 2010
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of novaferon in Chronic Hepatitis B (CHB) (3 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: Adverse events and HBV DNA level. Started Jul 2010; status: completed.

02

Drugs

novaferon
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-TRC-10000982.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000982.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call